1. Analyst View 2. Research Methodology 3. DNA Vaccine - An Introduction 4. Drivers & Challenges 4.1 Drivers 4.1.1 Increasing Investment 4.1.2 Advantages of DNA Vaccines over Traditional Vaccines 4.1.3 Dramatic Increase in Chronic Disorders 4.1.4 Strong DNA Vaccine Pipeline 4.1.5 Technological Advancements 4.2 Challenges 4.2.1 Uncertainty in Regulatory System 4.2.2 Lack of Awareness in Developing Countries 4.2.3 Development Limited to Plasmid Vectors 5. DNA Vaccine Market Overview 6. DNA Vaccines Market by Geography 6.1 North America 6.2 Europe 6.3 Asia Pacific 7. DNA Vaccine Market by Type 7.1 Recombinant Protein Vaccines 7.1.1 By Geography (North America, Europe, Asia Pacific) 7.2 Genetic Vaccines 7.2.1 By Geography (North America, Europe, Asia-Pacific) 8. DNA Vaccines Market by End User 8.1 Human 8.2 Animal 9. DNA Vaccines Market by Therapeutic Indication 9.1 Infectious & Vector Borne Diseases 9.2 Cancer 10. Pipeline Analysis 11. Trends 11.1 Increasing Focus on Genetic Vaccine Development 11.2 Expanding Applications Increasing Popularity of DNA Vaccines 11.3 Partnerships Enhancing Genetic Vaccines Development 12. Company Profiles 12.1 Novartis International AG 12.2 Merck & Co., Inc 12.3 GlaxoSmithKline plc. 12.4 Sanofi 12.5 Zoetis 12.6 Green Cross Corporation 12.7 Inovio Pharmaceuticals, Inc., 12.8 Bharat Biotech 12.9 Protein Sciences Corporation 12.10 Indian Immunologicals Ltd. 12.11 Serum Institute of India Pvt. Ltd 13. Recommendations

List of Tables: Table 10-1: Global - DNA Vaccines Pipeline Table 12-1: Novartis International AG - Product Portfolio Table 12-2: Novartis International AG - Pipeline Analysis Table 12-3: Novartis - Key Financials (Million US$), 2015-2017 Table 12-4: Merck & Co. Inc - Product Portfolio Table 12-5: Merck & Co. Inc - Key Financials (Million US$), 2015-2017 Table 12-6: GlaxoSmithKline - Product Portfolio Table 12-7: GlaxoSmithKline - Key Financials (Million US$), 2015-2017 Table 12-8: Sanofi - Product Portfolio Table 12-9: Sanofi - Pipeline Analysis Table 12-10: Sanofi - Key Financials (Million US$), 2015-2017 Table 12-11: Zoetis - Product Portfolio Table 12-12: Zoetis - Key Financials (Million US$), 2015-2017 Table 12-13: Green Cross Corporation - Product Portfolio Table 12-14: Green Cross Corporation - Key Financials (Million US$), 2015-2017 Table 12-15: Inovio Pharmaceuticals - Key Financials (Million US$), 2015-2017 Table 12-16: Inovio Pharmaceuticals - Pipeline Analysis Table 12-17: Bharat Biotech - Product Portfolio Table 12-18: Protein Sciences Corporation - Product Portfolio Table 12-19: Protein Sciences Corporation - Pipeline Analysis Table 12-20: Indian Immunologicals Ltd. - Product Portfolio Table 12-21: Serum Institute of India Pvt. Ltd - Product Portfolio Table 12-22: Serum Institute of India Ltd. - Pipeline Analysis List of Figures: Figure 5-1: Share of DNA Vaccines in Global Vaccine Market (%), 2016 Figure 5-2: Share of DNA Vaccines in Global Vaccine Market (%), 2022 Figure 5-3: Global - DNA Vaccine Market (Billion US$), 2016-2022 Figure 6-1: Global - DNA Vaccine Market by Geography (%), 2016 Figure 6-2: Global - DNA Vaccine Market by Geography (%), 2022 Figure 6-3: North America - DNA Vaccine Market (Billion US$), 2016 & 2022 Figure 6-4: Europe - DNA Vaccine Market (Billion US$), 2016 & 2022 Figure 6-5: Asia Pacific - DNA Vaccine Market (Billion US$), 2016 & 2022 Figure 7-1: Global - DNA Vaccine Market by Type (%), 2016 Figure 7-2: Global - DNA Vaccine Market by Type (%), 2022 Figure 7-3: Global - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022 Figure 7-4: Global - Recombinant Protein Vaccines Market by Geography (%), 2016 Figure 7-5: Global - Recombinant Protein Vaccines Market by Geography (%), 2022 31 Figure 7-6: North America - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022 Figure 7-7: Europe - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022 Figure 7-8: Asia Pacific - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022 Figure 7-9: Global - Genetic Vaccines Market (Billion US$), 2016 & 2022 Figure 7-10: Global - Genetic Vaccines Market by Geography (%), 2016 Figure 7-11: Global - Genetic Vaccines Market by Geography (%), 2022 Figure 7-12: North America - Genetic Vaccines Market (Billion US$), 2016 & 2022 Figure 7-13: Europe - Genetic Vaccines Market (Billion US$), 2016 & 2022 Figure 7-14: Asia Pacific - Genetic Vaccines Market (Billion US$), 2016 & 2022 Figure 8-1: Global - DNA Vaccine Market by End User (%), 2016 Figure 8-2: Global - DNA Vaccine Market by End User (%), 2022 Figure 8-3: Global - Human DNA Vaccine Market (Billion US$), 2016 & 2022 Figure 8-4: Global - Animal DNA Vaccine Market (Billion US$), 2016 & 2022 Figure 9-1: Global - DNA Vaccine Market by Therapeutic Segment (%), 2016 Figure 9-2: Global - DNA Vaccine Market by Therapeutic Segment (%), 2022 Figure 9-3: Global - DNA Vaccine Market for Infectious & Vector Borne Diseases (Billion US$), 2016 & 2022 Figure 9-4: Global - DNA Vaccine Market for Cancer (Billion US$), 2016 & 2022 Figure 10-1: Global - DNA Vaccine Pipeline Analysis by Phase (%), 2016 Figure 10-2: Global - DNA Vaccine Pipeline by Therapeutic Indication (%), 2016 Figure 10-3: Global - DNA Vaccine Pipeline by Vaccine Type (%), 2016 Figure 10-4: Global - DNA Vaccine Pipeline by Application (%), 2016 Figure 12-1: Novartis - Break-up of Revenue by Business Segment (%), 2017 Figure 12-2: Novartis - Break-up of Revenue by Geographical Region (%), 2017 Figure 12-3: Merck & Co. Inc - Break-up of Revenue by Business Segment (%), 2017 Figure 12-4: Merck & Co. Inc - Break-up of Revenue by Geographical Region (%), 2017 Figure 12-5: GlaxoSmithKline - Break-up of Revenue by Business Segment (%), 2017 Figure 12-6: GlaxoSmithKline - Break-up of Revenue by Geographical Region (%), 2017 Figure 12-7: Sanofi - Break-up of Revenue by Business Segment (%), 2017 Figure 12-8: Sanofi - Break-up of Revenue by Geographical Region (%), 2017 Figure 12-9: Zoetis - Break-up of Revenue by Business Segment (%), 2017 Figure 12-10: Zoetis - Break-up of Revenue by Geographical Region (%), 2017 Figure 12-11: Green Cross Corporation - Break-up of Revenue by Geographical Region (%), 2017